Top Pharmaceuticals stocks in Europe
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
NOVO BNovo Nordisk A/S | DKK4.09tn | 46.57 | 1.01% |
AZNAstraZeneca | £188.97bn | 43.36 | 1.87% |
ROGRoche Holding AG | CH₣182.01bn | 12.69 | 4.2% |
RORoche Holding AG | CH₣182.01bn | 13.9 | 3.84% |
NOVNNovartis AG | CH₣178.49bn | 17.79 | 3.88% |
SANSanofi SA | €112.32bn | 16.99 | 4.19% |
GSKGSK | £73.22bn | 13.99 | 3.34% |
MRKMerck KGaA | €72.39bn | 23.09 | 1.32% |
HLNHALEON | £29.69bn | 21.04 | 1.85% |
BAYNBayer AG | €27.74bn | 22.11 | 0.39% |
UCBUCB SA | €24.41bn | 91.98 | 0.74% |
SDZSandoz AG | CH₣13.64bn | 12.48 | 1.52% |
RECRecordati Industria Chimica E Farmaceutica SpA | €9.99bn | 26.32 | 2.48% |
IPNIpsen SA | €9.97bn | 22.94 | 1% |
SOBISwedish Orphan Biovitrum AB (publ) | SEK95.98bn | 36.21 | n/a |
GRFGrifols SA | €6.33bn | 18.12 | n/a |
ORNBVOrion Oyj | €5.27bn | 24.22 | 4.32% |
DPHDechra Pharmaceuticals | £4.40bn | 67.15 | n/a |
HIKHikma Pharmaceuticals | £4.28bn | 11.11 | 2.95% |
CLS1McKesson Europe AG | €4.96bn | n/a | n/a |